AAAAAA

   
Results: 1-10 |
Results: 10
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer
Authors: Sener, SF Milos, S Feldman, JL Martz, CH Winchester, DJ Dieterich, M Locker, GY Khandekar, JD Brockstein, B Haid, M Michel, A
Citation: Sf. Sener et al., The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer, J AM COLL S, 193(1), 2001, pp. 22-28
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer
Authors: Brockstein, B Samuels, B Humerickhouse, R Arietta, R Fishkin, P Wade, J Sosman, J Vokes, EE
Citation: B. Brockstein et al., Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer, INV NEW DR, 19(3), 2001, pp. 249-254
Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?
Authors: Brockstein, B
Citation: B. Brockstein, Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?, CURR OPIN O, 12(3), 2000, pp. 221-228
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer
Authors: Brockstein, B Haraf, DJ Stenson, K Sulzen, L Witt, ME Weichselbaum, RW Vokes, EE
Citation: B. Brockstein et al., A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer, ANN ONCOL, 11(6), 2000, pp. 721-728
NCCN Practice Guidelines for head and neck cancers
Authors: Forastiere, AA Pfister, DG Ang, K Brockstein, B Colevas, AD Ellenhorn, J Goepfert, H Hicks, WL Hong, WK Kies, MS Lydiatt, W McCaffrey, T Mittal, BB Ridge, JA Schuller, DE Shah, JP Spencer, S Trotti, A Urba, S Weymuller, EA Wheeler, RH Wolf, GT
Citation: Aa. Forastiere et al., NCCN Practice Guidelines for head and neck cancers, ONCOLOGY-NY, 14(11A), 2000, pp. 163-194
Swallowing function in patients with head and neck cancer prior to treatment
Authors: Stenson, KM MacCracken, E List, M Haraf, DJ Brockstein, B Weichselbaum, R Vokes, EE
Citation: Km. Stenson et al., Swallowing function in patients with head and neck cancer prior to treatment, ARCH OTOLAR, 126(3), 2000, pp. 371-377
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer
Authors: Kies, MS Haraf, DJ Rosen, F Stenson, K List, M Brockstein, B Chung, T Mittal, BB Pelzer, H Portugal, L Rademaker, A Weichselbaum, R Vokes, EE
Citation: Ms. Kies et al., Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer, J CL ONCOL, 19(7), 2000, pp. 1961-1969
Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer
Authors: Lad, T Rosen, F Sciortino, D Brockstein, B Keubler, JP Arietta, R Vokes, E
Citation: T. Lad et al., Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer, INV NEW DR, 18(3), 2000, pp. 261-263
Benefits of chemotherapy in head and neck cancer
Authors: Brockstein, B
Citation: B. Brockstein, Benefits of chemotherapy in head and neck cancer, LANCET, 356(9231), 2000, pp. 767-767
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrentor advanced head and neck cancer
Authors: Humerickhouse, RA Dolan, ME Haraf, DJ Brockstein, B Stenson, K Kies, M Sulzen, L Ratain, MJ Vokes, EE
Citation: Ra. Humerickhouse et al., Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrentor advanced head and neck cancer, CLIN CANC R, 5(2), 1999, pp. 291-298
Risultati: 1-10 |